🔗 Permalink

Inventor profile of:

Patrick Baumhof

City:

Dusslingen

Country:

Germany

Published Applications:

66

Last publication date:

2026-04-02

Top Assignees for applications by Patrick Baumhof

The entities that hold a legal rights for patent applications filed by inventor Baumhof Patrick:

CureVac AG 43 Tübingen, Germany
CureVac SE 9 Tübingen, Germany
CureVac GmbH 7 Tubingen, Germany
CUREVAC GMBH 4 Tuebingen, Germany
Qiagen GmbH 3 Hilden, Germany
Acuitas Therapeutics, Inc. 3 Vancouver, Canada
CureVac AG 1 Tubimgen, Germany

Recent patent applications by Baumhof Patrick

Patrick Baumhof from Dusslingen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-02

US20260090989A1

Human necessities

LIPID NANOPARTICLE mRNA VACCINES

#2 | 2025-09-18

US20250288522A1

Human necessities

LIPID NANOPARTICLE mRNA VACCINES

#3 | 2025-07-03

US20250213724A1

Human necessities

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

#4 | 2024-03-28

US20240101608A1

Chemistry; metallurgy

OPTIMIZED NUCLEIC ACID MOLECULES

#5 | 2023-10-26

US20230338579A1

Human necessities

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

#6 | 2023-09-28

US20230302146A1

Human necessities

HYBRID CARRIERS FOR NUCLEIC ACID CARGO

#7 | 2023-09-14

US20230285594A1

Human necessities

COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION

#8 | 2023-06-22

US20230190578A1

Human necessities

REVERSIBLE IMMOBILIZATION AND/OR CONTROLLED RELASE OF NUCLEIC ACID CONTAINING NANOPARTICLES BY (BIODEGRADABLE) POLYMER COATINGS

#9 | 2021-08-19

US20210251898A1

Human necessities

LIPID NANOPARTICLE MRNA VACCINES

#10 | 2021-03-04

US20210060175A1

Human necessities

METHODS OF IMMUNOSTIMULATION WITH COMPLEXES OF RNA AND CATIONIC CARRIERS

#11 | 2020-12-24

US20200399322A1

Chemistry; metallurgy

OPTIMIZED NUCLEIC ACID MOLECULES

#12 | 2020-10-29

US20200338215A1

Human necessities

DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS

#13 | 2020-06-11

US20200179526A1

Human necessities

Hybrid carriers for nucleic acid cargo

#14 | 2020-03-19

US20200085943A1

Human necessities

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

#15 | 2019-12-19

US20190381180A1

Human necessities

HYBRID CARRIERS FOR NUCLEIC ACID CARGO

#16 | 2019-11-07

US20190336611A1

Human necessities

HYBRID CARRIERS FOR NUCLEIC ACID CARGO

#17 | 2019-11-07

US20190336608A1

Human necessities

CATIONIC CARRIERS FOR NUCLEIC ACID DELIVERY

#18 | 2019-07-18

US20190216951A1

Human necessities

Method for increasing expression of RNA-encoded proteins

#19 | 2019-06-13

US20190175760A1

Human necessities

METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE WITH mRNA ENCODING GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT (G6PC)

#20 | 2019-06-13

US20190175759A1

Human necessities

METHODS OF TREATING A SUBJECT HAVING PROPIONIC ACIDEMIA WITH mRNA ENCODING PROPIONYL-COA CARBOXYLASE, SUBUNIT ALPHA AND/OR BETA (PCCA AND/OR PCCB)

#21 | 2019-06-13

US20190175758A1

Human necessities

METHODS OF TREATING A SUBJECT HAVING CITRULLINEMIA WITH mRNA ENCODING ARGININOSUCCINATE SYNTHASE (ASS)

#22 | 2019-06-13

US20190175757A1

Human necessities

METHODS OF TREATING A SUBJECT HAVING FRIEDREICH'S ATAXIA WITH mRNA ENCODING FRATAXIN

#23 | 2019-06-13

US20190175756A1

Human necessities

METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE II WITH mRNA ENCODING ACID GLUCOSIDASE ALPHA (GAA)

#24 | 2019-06-06

US20190167809A1

Human necessities

METHODS OF TREATING A SUBJECT WITH mRNA ENCODING COAGULATION FACTOR VIII (F8)

#25 | 2019-06-06

US20190167808A1

Human necessities

METHODS OF TREATING PHENYLKETONURIA WITH MRNA ENCODING PHENYLALANINE HYDROXYLASE (PAH)

#26 | 2019-05-23

US20190151469A1

Human necessities

RNA containing composition for treatment of tumor diseases

#27 | 2019-02-21

US20190054189A1

Human necessities

RNA containing composition for treatment of tumor diseases

#28 | 2019-01-10

US20190008954A1

Human necessities

NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION

#29 | 2018-11-01

US20180312545A1

Chemistry; metallurgy

OPTIMIZED NUCLEIC ACID MOLECULES

#30 | 2018-11-01

US20180311379A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#31 | 2018-10-18

US20180296663A1

Human necessities

VACCINE COMPOSITION

#32 | 2018-08-23

US20180236102A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#33 | 2018-07-26

US20180207295A1

Human necessities

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

#34 | 2018-06-21

US20180169267A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#35 | 2018-06-21

US20180169266A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#36 | 2018-06-14

US20180161457A1

Human necessities

Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids

#37 | 2018-06-14

US20180161454A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#38 | 2018-06-14

US20180161453A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#39 | 2018-06-14

US20180161452A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#40 | 2018-06-14

US20180161451A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#41 | 2018-05-10

US20180126005A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#42 | 2018-05-03

US20180117179A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#43 | 2017-08-24

US20170239372A1

Human necessities

REVERSIBLE IMMOBILIZATION AND/OR CONTROLLED RELASE OF NUCLEIC ACID CONTAINING NANOPARTICLES BY (BIODEGRADABLE) POLYMER COATINGS

#44 | 2017-05-11

US20170128549A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#45 | 2017-03-09

US20170065727A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#46 | 2017-02-02

US20170028059A1

Human necessities

Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates

#47 | 2017-01-05

US20170000858A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#48 | 2016-12-22

US20160367704A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#49 | 2016-11-17

US20160331844A1

Human necessities

RNA containing composition for treatment of tumor diseases

#50 | 2016-11-03

US20160317679A1

Human necessities

Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids

#51 | 2016-06-30

US20160184406A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#52 | 2016-06-16

US20160166710A1

Human necessities

Method for increasing expression of RNA-encoded proteins

#53 | 2015-10-29

US20150306249A1

Human necessities

REVERSIBLE IMMOBILIZATION AND/OR CONTROLLED RELEASE OF NUCLEIC ACID CONTAINING NANOPARTICLES BY (BIODEGRADABLE) POLYMER COATINGS

#54 | 2015-09-17

US20150258214A1

Human necessities

COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION

#55 | 2015-04-30

US20150118264A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

#56 | 2015-04-30

US20150118183A1

Human necessities

NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION

#57 | 2014-10-02

US20140294877A1

Human necessities

Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids

#58 | 2014-02-06

US20140037660A1

Chemistry; metallurgy

Complexes of RNA and cationic peptides for transfection and for immunostimulation

#59 | 2013-10-03

US20130259879A1

Human necessities

Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates

#60 | 2013-06-06

US20130142818A1

Human necessities

Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation

#61 | 2013-05-30

US20130137586A1

Chemistry; metallurgy

STABILIZATION OF NUCLEIC ACIDS IN CELL MATERIAL-CONTAINING BIOLOGICAL SAMPLES

#62 | 2012-11-08

US20120283426A1

Chemistry; metallurgy

Methods and kit for isolating nucleic acids

#63 | 2012-08-30

US20120219573A1

Human necessities

Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids

#64 | 2011-03-03

US20110053829A1

Human necessities

DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS

#65 | 2010-08-12

US20100203076A1

Human necessities

COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION

#66 | 2010-03-04

US20100056769A1

Chemistry; metallurgy

Methods and kit for isolating nucleic acids

InventorID:

273949 ⎘